Please use this identifier to cite or link to this item: http://hdl.handle.net/10668/3193
Title: Preservation of renal function in cardiac surgery patients with low cardiac output syndrome: levosimendan vs beta agonists
Authors: Guerrero Orriach, Jose Luis
Navarro Arce, I.
Hernandez Rodriguez, P.
Raigón Ponferrada, A.
Malo Manso, A.
Ramirez Aliaga, M.
Ramirez Fernandez, A.
Escalona Belmonte, J.J.
Bellido Estevez, I.
Gomez Luque, A.
Barrera Serrano, R.
Toledo Medina, C.S.
Rubio Navarro, M.
Cruz Mañas, J.
metadata.dc.contributor.authoraffiliation: [Guerrero Orriach,JL; Raigón Ponferrada,A; Malo Manso,A; Ramirez Aliaga,M; Ramirez Fernandez,A; Escalona Belmonte,JJ; Bellido Estevez,I; Gomez Luque,A; Rubio Navarro,M; Cruz Mañas,J] Institute of Biomedical Research in Malaga [IBIMA], Malaga, Spain. [Guerrero Orriach,JL; Navarro Arce,I; Hernandez Rodriguez,P; Raigón Ponferrada,A; Malo Manso,A; Ramirez Aliaga,M; Ramirez Fernandez,A; Escalona Belmonte,JJ; Gomez Luque,A; Barrera Serrano,R; Toledo Medina,CS; Rubio Navarro,M; Cruz Mañas,J] Department of Anaesthesiology, Virgen de la Victoria University Hospital, Malaga, Spain. [Guerrero Orriach,JL; Bellido Estevez,I; Gomez Luque,A] Department of Pharmacology and Pediatrics, School of Medicine, University of Malaga, Malaga, Spain.
Keywords: Levosimendan;Low cardiac output;Kidney;Cardiac surgery;Simendán;Gasto cardíaco bajo;Riñón;Cirugía torácica
metadata.dc.subject.mesh: Medical Subject Headings::Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Molecular Mechanisms of Pharmacological Action::Neurotransmitter Agents::Adrenergic Agents::Adrenergic Agonists::Adrenergic beta-Agonists
Medical Subject Headings::Persons::Persons::Age Groups::Adult::Aged
Medical Subject Headings::Persons::Persons::Age Groups::Adult::Aged::Aged, 80 and over
Medical Subject Headings::Diseases::Cardiovascular Diseases::Heart Diseases::Cardiac Output, Low
Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Surgical Procedures, Operative::Cardiovascular Surgical Procedures::Cardiac Surgical Procedures
Medical Subject Headings::Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Cardiovascular Agents::Cardiotonic Agents
Medical Subject Headings::Check Tags::Female
Medical Subject Headings::Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans
Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Data Collection::Vital Statistics::Morbidity::Incidence
Medical Subject Headings::Check Tags::Male
Medical Subject Headings::Persons::Persons::Age Groups::Adult::Middle Aged
Medical Subject Headings::Diseases::Pathological Conditions, Signs and Symptoms::Pathologic Processes::Postoperative Complications
Medical Subject Headings::Diseases::Male Urogenital Diseases::Urologic Diseases::Kidney Diseases::Renal Insufficiency
Medical Subject Headings::Diseases::Female Urogenital Diseases and Pregnancy Complications::Female Urogenital Diseases::Urologic Diseases::Kidney Diseases::Renal Insufficiency
Issue Date: 17-Nov-2019
Publisher: BioMed Central Ltd.
Citation: Guerrero Orriach JL, Navarro Arce I, Hernandez Rodriguez P, Raigón Ponferrada A, Malo Manso A, Ramirez Aliaga M, et al. Preservation of renal function in cardiac surgery patients with low cardiac output syndrome: levosimendan vs beta agonists. BMC Anesthesiol. 2019 Nov 17;19(1):212.
Abstract: Background: Some studies have been performed to assess the effects of levosimendan on cardiac function when administered to cardiac surgery patients with low cardiac output syndrome (LCOS) in the immediate postoperative period. Levosimendan is an inotropic agent for the treatment of low cardiac output syndrome that seems to have a protective effect on renal function. Methods: It is a quasi-experimental study. A total of 100 patients with LCOS received either beta-agonists or levosimendan. We assessed the incidence of postoperative kidney failure in cardiac surgery patients. In patients who had kidney failure at diagnosis of LCOS, we examined whether differences existed in the evolution of kidney failure based on the treatment administered for LCOS. The parameters measured included haemodynamics, oxygen supply, and renal function as assessed by the AKI scale. ANOVA, Student's t-test and Wilcoxon or Friedman tests were used. Results: Up to 30% of cardiac surgery patients had kidney failure at diagnosis of LCOS. Kidney failure at discharge from the ICU was more frequent in patients who received beta-agonist drugs as compared to those who received levosimendan (p < 0.05). Conclusion: The incidence of kidney failure decreased with the postoperative administration of levosimendan to cardiac surgery patients with LCOS, as compared to beta-agonists. Trial registration: Current Controlled Trials ISRCTN 46058317. Date of registration: 7/10/2019. Retrospectively registered.
URI: http://hdl.handle.net/10668/3193
metadata.dc.relation.publisherversion: https://bmcanesthesiol.biomedcentral.com/articles/10.1186/s12871-019-0888-2
metadata.dc.identifier.doi: 10.1186/s12871-019-0888-2
ISSN: 1471-2253 (Online)
Appears in Collections:01- Artículos - Hospital Virgen de la Victoria
01- Artículos - IBIMA. Instituto de Investigación Biomédica de Málaga

Files in This Item:
File Description SizeFormat 
Guerrero_PreservationOfRenal.pdfArtículo publicado510,68 kBAdobe PDFView/Open


This item is protected by original copyright



This item is licensed under a Creative Commons License Creative Commons